After Stem Cell Transplant: The Cardiovascular Late Effects That Need a Schedule
Conditioning regimens, total body irradiation, graft-versus-host disease, and long steroid exposure combine into a distinct cardiovascular risk profile that general screening intervals do not cover.
Transplant survivors carry a cardiovascular risk profile that no single guideline covers well, because it is built from several exposures at once: prior anthracyclines, conditioning chemotherapy, sometimes total body irradiation, prolonged steroids, and chronic graft-versus-host disease.
Why the profile is distinct
Most transplant recipients arrive with prior anthracycline exposure. Conditioning adds high-dose chemotherapy and, in some regimens, total body irradiation, which affects the heart, vessels, and thyroid. Post-transplant, prolonged corticosteroids and calcineurin inhibitors drive hypertension, glucose intolerance, and dyslipidaemia, and chronic graft-versus-host disease adds sustained inflammation.
The result is that metabolic syndrome and early vascular disease appear more often and sooner than age alone would predict.
What surveillance should include
Blood pressure at every contact, lipids and HbA1c on a set interval, thyroid function where the neck or total body was irradiated, and echocardiography at an interval set by cumulative anthracycline dose and radiation exposure. Iron overload from repeated transfusion is worth assessing where transfusion burden was high, since it affects the heart directly.
Renal function belongs in the same panel, both because calcineurin inhibitors affect it and because it changes cardiac risk and dosing.
The handover problem
Transplant-centre follow-up eventually steps down, often to a primary care team that has not seen the conditioning regimen. Without a written long-term follow-up plan naming the exposures and the intervals, surveillance stops. Request that plan explicitly at the point of step-down and ask for a copy for your own records.
What survivors can act on
Blood pressure control, activity rebuilding within the limits of graft-versus-host disease and fatigue, and early treatment of glucose and lipid drift deliver most of the available benefit. Report breathlessness, swelling, or reduced exercise tolerance rather than accepting them as part of transplant recovery, particularly beyond the first year.
Frequently asked questions
- What are the cardiovascular late effects of a stem cell transplant?
- Earlier metabolic syndrome, hypertension, dyslipidaemia, glucose intolerance, cardiomyopathy from cumulative anthracycline and conditioning exposure, thyroid dysfunction after irradiation, and effects from iron overload after heavy transfusion.
- Who should monitor heart health after transplant follow-up ends?
- A named clinician working from a written long-term follow-up plan that lists the exposures and surveillance intervals, usually primary care with input from late effects or cardio-oncology services.